Pharmacielo Stock Revenue
PCLO Stock | CAD 0.09 0.01 5.88% |
Pharmacielo fundamentals help investors to digest information that contributes to Pharmacielo's financial success or failures. It also enables traders to predict the movement of Pharmacielo Stock. The fundamental analysis module provides a way to measure Pharmacielo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmacielo stock.
Last Reported | Projected for Next Year | ||
Total Revenue | 1.5 M | 2.2 M |
Pharmacielo | Revenue |
Pharmacielo Company Revenue Analysis
Pharmacielo's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Pharmacielo Revenue | 1.54 M |
Most of Pharmacielo's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmacielo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Pharmacielo
Projected quarterly revenue analysis of Pharmacielo provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Pharmacielo match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Pharmacielo's stock price.
Pharmacielo Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Pharmacielo is extremely important. It helps to project a fair market value of Pharmacielo Stock properly, considering its historical fundamentals such as Revenue. Since Pharmacielo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pharmacielo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pharmacielo's interrelated accounts and indicators.
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Pharmacielo Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Pharmacielo reported 1.54 M of revenue. This is 99.98% lower than that of the Pharmaceuticals sector and 99.93% lower than that of the Health Care industry. The revenue for all Canada stocks is 99.98% higher than that of the company.
Pharmacielo is regarded second in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 64.7 Million. Pharmacielo holds roughly 1.54 Million in revenue claiming about 2.38% of equities under Health Care industry.Pharmacielo Fundamentals
Return On Equity | -30.13 | ||||
Return On Asset | -0.2 | ||||
Operating Margin | (2.12) % | ||||
Current Valuation | 34.53 M | ||||
Shares Outstanding | 169.74 M | ||||
Shares Owned By Insiders | 8.43 % | ||||
Shares Owned By Institutions | 4.58 % | ||||
Number Of Shares Shorted | 28.63 K | ||||
Price To Book | 9.48 X | ||||
Price To Sales | 8.91 X | ||||
Revenue | 1.54 M | ||||
Gross Profit | (4.17 M) | ||||
EBITDA | (7.56 M) | ||||
Net Income | (16.3 M) | ||||
Cash And Equivalents | 33.46 M | ||||
Cash Per Share | 0.34 X | ||||
Total Debt | 15.71 M | ||||
Debt To Equity | 2.70 % | ||||
Current Ratio | 7.36 X | ||||
Book Value Per Share | (0.03) X | ||||
Cash Flow From Operations | (5.15 M) | ||||
Short Ratio | 0.11 X | ||||
Earnings Per Share | (0.08) X | ||||
Target Price | 2.5 | ||||
Beta | 2.39 | ||||
Market Capitalization | 14.43 M | ||||
Total Asset | 22.29 M | ||||
Retained Earnings | (198.71 M) | ||||
Working Capital | (18.09 M) | ||||
Net Asset | 22.29 M |
About Pharmacielo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmacielo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmacielo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmacielo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharmacielo Stock Analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.